InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Bohen Sean, Chief Executive Officer. Insider active across 1 company, notably Olema Pharmaceuticals, Inc.. Cumulatively, 9 filings have been recorded. Split: 1 buy · 0 sell. Activity tracked since 1 September 2021. The latest transaction was filed on 26 December 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bohen Sean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
8,500 shares0Common StockSEC:0001831218-25-000004:0
204,750 shares0Common StockSEC:0001415889-24-029024:0
110,250 shares0Common StockSEC:0001415889-23-015456:0
20,000 sharesCommon StockSEC:0001415889-22-009915:0
Canonical exit: 20 Dec 2022 (T+90)
20,000 sharesCommon StockSEC:0001415889-22-009880:0
5,000 shares@ US$4.82468.2% of flowCommon StockSEC:0001415889-21-004885:0
1,085 shares@ US$4.82414.7% of flowCommon StockSEC:0001415889-21-004613:0
413 shares@ US$4.8245.5% of flowCommon StockSEC:0001415889-21-004306:0
871 shares@ US$4.82411.6% of flowCommon StockSEC:0001415889-21-004247:0
9 of 9 declarations
About Bohen Sean
Bohen Sean is Directeur Général and serves as President and CEO at Olema Pharmaceuticals, Inc. The record shows 9 filings in total, and across the 9 sampled filings between 2021-09-03 and 2025-12-30, the most frequent transaction nature is option exercise, with sum_buy_eur at 0 and sum_sell_eur at 0.
